Search





Search





Markets
/
Stocks
/
nasdaq-elox
/

Eloxx Pharmaceuticals Ord Shs

ELOX

Add to Watchlist

12.000USD

-0.210-1.72%

Close 06/24, 16:00（ET）Quotes delayed by 15 min

49.28MMarket Cap

--P/E TTM

Eloxx Pharmaceuticals Ord Shs

12.000

-0.210-1.72%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can access the annual and quarterly cash flow statements of Eloxx Pharmaceuticals Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---5.45M

Net income from continuing operations

---3.75M

Other non-cash items

---49.00K

Change in working capital

---1.70M

-Change in receivables

--0.00

-Change in prepaid expenses

---1.66M

Cash from non-recurring investing activities

Cash from operating activities

---5.45M

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

--7.03M

Net cash flow from debt Issuance/repayment

--0.00

Proceeds from stock option exercised by employees

--40.00K

Proceeds from issuance of warrants

--6.99M

Net cash from non-recurrent financing activities

Net cash from financing activities

--7.03M

Net cash flow

Beginning cash balance

--4.79M

Current period cash flow changes

--1.58M

Ending cash balance

--6.37M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

